OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish
Sofía de Oliveira, Ruth A. Houseright, Alyssa Graves, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 4, pp. 710-721
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 10, pp. 569-589
Closed Access | Times Cited: 524

Neutrophil phenotypes and functions in cancer: A consensus statement
Daniela F. Quail, Borko Amulic, Monowar Aziz, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 207

Association between SII and hepatic steatosis and liver fibrosis: A population-based study
Ruijie Xie, Mengde Xiao, Lihong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 149

Dietary fiber‐derived short‐chain fatty acids: A potential therapeutic target to alleviate obesity‐related nonalcoholic fatty liver disease
Shumin Zhang, Jingwen Zhao, Fei Xie, et al.
Obesity Reviews (2021) Vol. 22, Iss. 11
Closed Access | Times Cited: 145

Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 93

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao, Shilun Wu, Jian Kong, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 1, pp. 25-43
Open Access | Times Cited: 72

Targeting the NF-κB p65-MMP28 axis: Wogonoside as a novel therapeutic agent for attenuating podocyte injury in diabetic nephropathy
Xiandeng Li, Shuyan Zhao, Jing Xie, et al.
Phytomedicine (2025) Vol. 138, pp. 156406-156406
Open Access | Times Cited: 2

Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial
Shuhong Wang, Yusheng Lin, Xiao Xiong, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 18, pp. 4921-4932
Open Access | Times Cited: 127

Metformin: A Novel Weapon Against Inflammation
Bo Bai, Haibo Chen
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 97

Distinct inflammatory and wound healing responses to complex caudal fin injuries of larval zebrafish
Veronika Miskolci, Jayne M. Squirrell, Julie Rindy, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 89

Metformin: current clinical applications in nondiabetic patients with cancer
Kailin Chen, Yajun Li, Zhen Guo, et al.
Aging (2020) Vol. 12, Iss. 4, pp. 3993-4009
Open Access | Times Cited: 79

Determining macrophage versus neutrophil contributions to innate immunity using larval zebrafish
Emily E. Rosowski
Disease Models & Mechanisms (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 73

Diabetes medications and risk of HCC
Maria Corina Plaz Torres, Ariel Jaffe, Rachel J. Perry, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1880-1897
Open Access | Times Cited: 59

In vivo fluorescence lifetime imaging of macrophage intracellular metabolism during wound responses in zebrafish
Veronika Miskolci, Kelsey Tweed, Michael Lasarev, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 44

Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice
Guangfu Wang, Hao Gao, Shangnan Dai, et al.
Cancer Letters (2023) Vol. 562, pp. 216155-216155
Closed Access | Times Cited: 32

Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017–2020
Chunfeng Lu, Xiaomin Cang, Wangshu Liu, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 26

Zebrafish as a Useful Model System for Human Liver Disease
Nobuyuki Shimizu, Hiroshi Shiraishi, Toshikatsu Hanada
Cells (2023) Vol. 12, Iss. 18, pp. 2246-2246
Open Access | Times Cited: 25

The Role and Mechanism of Metformin in Inflammatory Diseases
Huan Lin, Haiyong Ao, Guang‐hua Guo, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5545-5564
Open Access | Times Cited: 23

Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome
Qiuyu Xu, Jie Zhang, Yan Lü, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108783-108783
Open Access | Times Cited: 12

Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11

Macrophages and T cells in metabolic disorder-associated cancers
Daniel Taranto, Daan J. Kloosterman, Leila Akkari
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9

Metformin and the Liver: Unlocking the Full Therapeutic Potential
Federica Perazza, Laura Leoni, Santo Colosimo, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 186-186
Open Access | Times Cited: 8

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors
Hao Li, Shuai Wang, Zhengqiang Yang, et al.
Bioactive Materials (2024) Vol. 36, pp. 376-412
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top